ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 761

$495K Total Retail Price of All Prescriptions

Rank: 131 out of 761

611 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 619 569 1 2
LISINOPRIL 394 325 2 1
LEVOTHYROXINE SODIUM 384 356 3 3
AMLODIPINE BESYLATE 353 326 4 6
FUROSEMIDE 286 228 5 7
POTASSIUM CHLORIDE 278 259 6 18
HYDROCODONE-ACETAMINOPHEN 274 200 S3 7 5
OMEPRAZOLE 274 224 7 4
ATENOLOL 270 251 9 8
ALENDRONATE SODIUM 214 211 10 21
LOSARTAN POTASSIUM 210 192 11 13
WARFARIN SODIUM 195 163 12 9
CARVEDILOL 195 165 12 26
GABAPENTIN 190 135 14 15
LOVASTATIN 190 153 14 17
METOPROLOL SUCCINATE 163 145 16 16
ZOLPIDEM TARTRATE 150 120 17 22
METFORMIN HCL 147 119 18 10
METOPROLOL TARTRATE 130 101 19 14
HYDROCHLOROTHIAZIDE 128 102 20 11
PREDNISONE 119 107 21 30
FLUTICASONE PROPIONATE 118 113 22 29
DIGOXIN 112 110 23 43
ATORVASTATIN CALCIUM 108 72 24 12
TRAZODONE HCL 97 71 25 23
ALLOPURINOL 89 83 26 28
PAROXETINE HCL 89 64 26 47
OXYCODONE HCL 81 36 S2 28 24
TRIAMTERENE-HCTZ 81 76 28 42
SERTRALINE HCL 81 42 28 25
CRESTOR 75 65 31 36
PRAVASTATIN SODIUM 75 69 31 20
CITALOPRAM HBR 71 60 33 19
TRAMADOL HCL 70 61 34 34
OXYCODONE-ACETAMINOPHEN 68 65 S2 35 49
CYCLOBENZAPRINE HCL 67 58 R 36 51
OXYBUTYNIN CHLORIDE 65 48 37 85
VENLAFAXINE HCL 65 41 37 198
SPIRONOLACTONE-HCTZ 56 54 39 177
AZITHROMYCIN 54 44 40 70
NEXIUM 54 29 40 98
TAMSULOSIN HCL 51 48 42 27
ESTRADIOL 51 25 R 42 80
PROAIR HFA 50 30 44 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.